
Rodney Evan Fuller
Examiner (ID: 15621, Phone: (571)272-2118 , Office: P/2852 )
| Most Active Art Unit | 2852 |
| Art Unit(s) | 2851, 2862, 2852 |
| Total Applications | 2640 |
| Issued Applications | 2163 |
| Pending Applications | 130 |
| Abandoned Applications | 373 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17928407
[patent_doc_number] => 20220323532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => COMPOSITIONS COMPRISING PLANT-DERIVED EXOSOME-LIKE NANOVESICLES OR EXOSOMES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/710929
[patent_app_country] => US
[patent_app_date] => 2022-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30175
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17710929
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/710929 | COMPOSITIONS COMPRISING PLANT-DERIVED EXOSOME-LIKE NANOVESICLES OR EXOSOMES AND METHODS OF USE THEREOF | Mar 30, 2022 | Pending |
Array
(
[id] => 20824960
[patent_doc_number] => 12678502
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-07-14
[patent_title] => Compositions having improved bioavailability of therapeutics
[patent_app_type] => utility
[patent_app_number] => 17/656702
[patent_app_country] => US
[patent_app_date] => 2022-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 54
[patent_no_of_words] => 184725
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 189
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17656702
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/656702 | Compositions Having Improved Bioavailability of Therapeutics | Mar 27, 2022 | Issued |
Array
(
[id] => 19202700
[patent_doc_number] => 20240174599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-30
[patent_title] => MALONAMIDES AND THEIR USE AS HERBICIDES
[patent_app_type] => utility
[patent_app_number] => 18/280408
[patent_app_country] => US
[patent_app_date] => 2022-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26818
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18280408
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/280408 | MALONAMIDES AND THEIR USE AS HERBICIDES | Mar 8, 2022 | Issued |
Array
(
[id] => 19246883
[patent_doc_number] => 20240197867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => NEURAL CONTROL OF ADAPTIVE IMMUNITY
[patent_app_type] => utility
[patent_app_number] => 18/278688
[patent_app_country] => US
[patent_app_date] => 2022-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3353
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18278688
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/278688 | NEURAL CONTROL OF ADAPTIVE IMMUNITY | Feb 24, 2022 | Pending |
Array
(
[id] => 17625815
[patent_doc_number] => 20220160830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => COMPOSITIONS COMPRISING CHOLINE
[patent_app_type] => utility
[patent_app_number] => 17/669781
[patent_app_country] => US
[patent_app_date] => 2022-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13362
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17669781
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/669781 | COMPOSITIONS COMPRISING CHOLINE | Feb 10, 2022 | Abandoned |
Array
(
[id] => 20756207
[patent_doc_number] => 12648955
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-06-09
[patent_title] => Method of treating ocular discomfort
[patent_app_type] => utility
[patent_app_number] => 17/573577
[patent_app_country] => US
[patent_app_date] => 2022-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 25
[patent_no_of_words] => 22559
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17573577
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/573577 | Method of treating ocular discomfort | Jan 10, 2022 | Issued |
Array
(
[id] => 18953644
[patent_doc_number] => 20240041971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => A PROCESS OF PREPARATION OF FLOUR MIX AND ITS USE FOR THE TREATMENT OF DIABETES
[patent_app_type] => utility
[patent_app_number] => 18/269216
[patent_app_country] => US
[patent_app_date] => 2021-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7964
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18269216
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/269216 | A PROCESS OF PREPARATION OF FLOUR MIX AND ITS USE FOR THE TREATMENT OF DIABETES | Dec 21, 2021 | Pending |
Array
(
[id] => 17561679
[patent_doc_number] => 20220125828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => ANTISEPTIC POLYMER AND SYNTHESIS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/557108
[patent_app_country] => US
[patent_app_date] => 2021-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8935
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17557108
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/557108 | Antiseptic polymer and synthesis thereof | Dec 20, 2021 | Issued |
Array
(
[id] => 17576930
[patent_doc_number] => 20220133785
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => THERAPEUTIC MATERIAL WITH LOW pH AND LOW TOXICITY ACTIVE AGAINST AT LEAST ONE PATHOGEN FOR ADDRESSING PATIENTS WITH RESPIRATORY ILLNESSES
[patent_app_type] => utility
[patent_app_number] => 17/547712
[patent_app_country] => US
[patent_app_date] => 2021-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13371
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17547712
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/547712 | Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses | Dec 9, 2021 | Issued |
Array
(
[id] => 20076222
[patent_doc_number] => 12350256
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-08
[patent_title] => Histidine and/or histidine derivative for the treatment of inflammatory skin diseases
[patent_app_type] => utility
[patent_app_number] => 17/545331
[patent_app_country] => US
[patent_app_date] => 2021-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 5
[patent_no_of_words] => 8421
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17545331
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/545331 | Histidine and/or histidine derivative for the treatment of inflammatory skin diseases | Dec 7, 2021 | Issued |
Array
(
[id] => 17701977
[patent_doc_number] => 20220201983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => PARASITICIDAL COLLAR COMPRISING ISOXAZOLINE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/457792
[patent_app_country] => US
[patent_app_date] => 2021-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31532
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17457792
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/457792 | Parasiticidal collar comprising isoxazoline compounds | Dec 5, 2021 | Issued |
Array
(
[id] => 17480432
[patent_doc_number] => 20220087936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => Enhanced Rodeferin Broad Spectrum
[patent_app_type] => utility
[patent_app_number] => 17/540277
[patent_app_country] => US
[patent_app_date] => 2021-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2083
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17540277
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/540277 | Enhanced Rodeferin Broad Spectrum | Dec 1, 2021 | Abandoned |
Array
(
[id] => 17640634
[patent_doc_number] => 20220168372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => FASTING-MIMICKING DIET PROMOTES CANCER-FREE SURVIVAL IN ACUTE LYMPHOBLASTIC LEUKEMIA MODELS
[patent_app_type] => utility
[patent_app_number] => 17/539726
[patent_app_country] => US
[patent_app_date] => 2021-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13626
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -46
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17539726
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/539726 | Fasting-mimicking diet promotes cancer-free survival in acute lymphoblastic leukemia models | Nov 30, 2021 | Issued |
Array
(
[id] => 17625794
[patent_doc_number] => 20220160809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => Stimulation of NK Cell Activity by QuadraMune Alone and together with Metformin
[patent_app_type] => utility
[patent_app_number] => 17/534292
[patent_app_country] => US
[patent_app_date] => 2021-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5436
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17534292
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/534292 | Stimulation of NK cell activity by using a combination of broccoli, Nigella Sativa, Green Tea, and pterostilbene alone and together with metformin | Nov 22, 2021 | Issued |
Array
(
[id] => 20192304
[patent_doc_number] => 20250269014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-28
[patent_title] => POLYSACCHARIDES FOR USE IN TREATING SARS-COV-2 INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 18/035640
[patent_app_country] => US
[patent_app_date] => 2021-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8339
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18035640
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/035640 | POLYSACCHARIDES FOR USE IN TREATING SARS-COV-2 INFECTIONS | Nov 4, 2021 | Pending |
Array
(
[id] => 17996656
[patent_doc_number] => 11497742
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-11-15
[patent_title] => Pharmaceutical composition for the treatment of Covid-19 infection
[patent_app_type] => utility
[patent_app_number] => 17/515322
[patent_app_country] => US
[patent_app_date] => 2021-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3430
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17515322
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/515322 | Pharmaceutical composition for the treatment of Covid-19 infection | Oct 28, 2021 | Issued |
Array
(
[id] => 17412612
[patent_doc_number] => 20220047516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => MODIFIED RELEASE COATED CAPSULES
[patent_app_type] => utility
[patent_app_number] => 17/510829
[patent_app_country] => US
[patent_app_date] => 2021-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7576
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17510829
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/510829 | Modified release coated capsules | Oct 25, 2021 | Issued |
Array
(
[id] => 18962823
[patent_doc_number] => 11896562
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-13
[patent_title] => Oral amphetamine composition
[patent_app_type] => utility
[patent_app_number] => 17/493949
[patent_app_country] => US
[patent_app_date] => 2021-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 13093
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 227
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17493949
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/493949 | Oral amphetamine composition | Oct 4, 2021 | Issued |
Array
(
[id] => 20200402
[patent_doc_number] => 12403167
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-02
[patent_title] => Phenylethanoid glycoside extract from
[patent_app_type] => utility
[patent_app_number] => 17/485995
[patent_app_country] => US
[patent_app_date] => 2021-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 0
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 182
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17485995
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/485995 | Phenylethanoid glycoside extract from | Sep 26, 2021 | Issued |
Array
(
[id] => 17790383
[patent_doc_number] => 20220249474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => IMMEDIATE RELEASE PHARMACEUTICAL FORMULATION OF 4-[3-(4-CYCLOPROPANECARBONYL-PIPERAZINE-1-CARBONYL)-4-FLUORO-BENZYL]-2H-PHTHALAZIN-1-ONE
[patent_app_type] => utility
[patent_app_number] => 17/483070
[patent_app_country] => US
[patent_app_date] => 2021-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13935
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17483070
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/483070 | IMMEDIATE RELEASE PHARMACEUTICAL FORMULATION OF 4-[3-(4-CYCLOPROPANECARBONYL-PIPERAZINE-1-CARBONYL)-4-FLUORO-BENZYL]-2H-PHTHALAZIN-1-ONE | Sep 22, 2021 | Abandoned |